These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 26687980

  • 41. PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation.
    Watzlawik JO, Warrington AE, Rodriguez M.
    PLoS One; 2013; 8(2):e55149. PubMed ID: 23383310
    [Abstract] [Full Text] [Related]

  • 42. Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS.
    Vana AC, Lucchinetti CF, Le TQ, Armstrong RC.
    Glia; 2007 May; 55(7):687-97. PubMed ID: 17330875
    [Abstract] [Full Text] [Related]

  • 43. Lesion stage-dependent causes for impaired remyelination in MS.
    Heß K, Starost L, Kieran NW, Thomas C, Vincenten MCJ, Antel J, Martino G, Huitinga I, Healy L, Kuhlmann T.
    Acta Neuropathol; 2020 Sep; 140(3):359-375. PubMed ID: 32710244
    [Abstract] [Full Text] [Related]

  • 44. Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.
    Patel JR, Williams JL, Muccigrosso MM, Liu L, Sun T, Rubin JB, Klein RS.
    Acta Neuropathol; 2012 Dec; 124(6):847-60. PubMed ID: 22933014
    [Abstract] [Full Text] [Related]

  • 45. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK, Blakemore WF.
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [Abstract] [Full Text] [Related]

  • 46. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
    Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin ZS, Kantor C, Sargent A, Quick KL, Schlatzer DM, Tang H, Papoian R, Brimacombe KR, Shen M, Boxer MB, Jadhav A, Robinson AP, Podojil JR, Miller SD, Miller RH, Tesar PJ.
    Nature; 2015 Jun 11; 522(7555):216-20. PubMed ID: 25896324
    [Abstract] [Full Text] [Related]

  • 47. Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
    Cui QL, Kuhlmann T, Miron VE, Leong SY, Fang J, Gris P, Kennedy TE, Almazan G, Antel J.
    Am J Pathol; 2013 Aug 11; 183(2):516-25. PubMed ID: 23746653
    [Abstract] [Full Text] [Related]

  • 48. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
    Van Strien ME, Baron W, Bakker EN, Bauer J, Bol JG, Brevé JJ, Binnekade R, Van Der Laarse WJ, Drukarch B, Van Dam AM.
    Glia; 2011 Nov 11; 59(11):1622-34. PubMed ID: 21818782
    [Abstract] [Full Text] [Related]

  • 49. Remyelination in multiple sclerosis.
    Chari DM.
    Int Rev Neurobiol; 2007 Nov 11; 79():589-620. PubMed ID: 17531860
    [Abstract] [Full Text] [Related]

  • 50. Cortical Remyelination Is Heterogeneous in Multiple Sclerosis.
    Strijbis EMM, Kooi EJ, van der Valk P, Geurts JJG.
    J Neuropathol Exp Neurol; 2017 May 01; 76(5):390-401. PubMed ID: 28521040
    [Abstract] [Full Text] [Related]

  • 51. Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
    Mei F, Mayoral SR, Nobuta H, Wang F, Desponts C, Lorrain DS, Xiao L, Green AJ, Rowitch D, Whistler J, Chan JR.
    J Neurosci; 2016 Jul 27; 36(30):7925-35. PubMed ID: 27466337
    [Abstract] [Full Text] [Related]

  • 52. Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.
    Boyd A, Zhang H, Williams A.
    Acta Neuropathol; 2013 Jun 27; 125(6):841-59. PubMed ID: 23595275
    [Abstract] [Full Text] [Related]

  • 53. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
    Khalaj AJ, Hasselmann J, Augello C, Moore S, Tiwari-Woodruff SK.
    J Steroid Biochem Mol Biol; 2016 Jun 27; 160():43-52. PubMed ID: 26776441
    [Abstract] [Full Text] [Related]

  • 54. Deciphering the Genetic Crosstalk between Microglia and Oligodendrocyte Precursor Cells during Demyelination and Remyelination Using Transcriptomic Data.
    Enrich-Bengoa J, Manich G, Dégano IR, Perálvarez-Marín A.
    Int J Mol Sci; 2022 Nov 28; 23(23):. PubMed ID: 36499195
    [Abstract] [Full Text] [Related]

  • 55. Donepezil, a drug for Alzheimer's disease, promotes oligodendrocyte generation and remyelination.
    Cui X, Guo YE, Fang JH, Shi CJ, Suo N, Zhang R, Xie X.
    Acta Pharmacol Sin; 2019 Nov 28; 40(11):1386-1393. PubMed ID: 30918344
    [Abstract] [Full Text] [Related]

  • 56. Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials.
    Sutiwisesak R, Burns TC, Rodriguez M, Warrington AE.
    Expert Opin Investig Drugs; 2021 Aug 28; 30(8):857-876. PubMed ID: 34126015
    [Abstract] [Full Text] [Related]

  • 57. Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.
    Chamberlain KA, Nanescu SE, Psachoulia K, Huang JK.
    Neuropharmacology; 2016 Nov 28; 110(Pt B):633-643. PubMed ID: 26474658
    [Abstract] [Full Text] [Related]

  • 58. Golli myelin basic proteins stimulate oligodendrocyte progenitor cell proliferation and differentiation in remyelinating adult mouse brain.
    Paez PM, Cheli VT, Ghiani CA, Spreuer V, Handley VW, Campagnoni AT.
    Glia; 2012 Jul 28; 60(7):1078-93. PubMed ID: 22447683
    [Abstract] [Full Text] [Related]

  • 59. [Novel remyelination strategy for multiple sclerosis in the era of oligodendrocytopathy].
    Nakahara J.
    Rinsho Shinkeigaku; 2012 Jul 28; 52(11):1351-3. PubMed ID: 23196615
    [Abstract] [Full Text] [Related]

  • 60. Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
    Williams JL, Patel JR, Daniels BP, Klein RS.
    J Exp Med; 2014 May 05; 211(5):791-9. PubMed ID: 24733828
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.